Central Medience's Acquisition
2025-09-01 07:27:18

Central Medience Completes Acquisition of Metran, Strengthening Medical Equipment Sector

Central Medience Acquires Metran



On September 1, Central Medience, headquartered in Minato-ku, Tokyo, announced the acquisition of all shares of Metran Co., Ltd., based in Kawaguchi, Saitama. This acquisition marks a significant milestone for Central Medience as it becomes a wholly-owned subsidiary of the company.

Background of the Acquisition


The share acquisition was executed based on a sponsorship agreement between the two companies. Metran was transformed into a complete subsidiary through a third-party allocation of shares, which highlights the strategic collaboration aimed at enhancing the capabilities and offerings in the medical equipment sector.

Business Synergy


Founded in 1984, Metran has been a pioneer in developing high-frequency oscillatory ventilators (HFO) for premature and newborn infants. The company has consistently responded to the medical field's needs using the latest technology, providing vital medical devices that contribute to saving and treating low birth weight infants and newborns in Neonatal Intensive Care Units (NICUs) across Japan and internationally.

Central Medience operates under the philosophy of “Never Stop Medical Care,” functioning as a Medical Integrator, providing comprehensive back-office business support required for medical institutions. Their services include management, resources, human services, procurement, logistics, and maintenance of medical devices. This well-integrated approach allows them to manage inventory and costs effectively in real-time, ensuring stable support for healthcare settings. The company aims to optimize healthcare management by creating environments where medical professionals can concentrate on their core duties, thus continuously providing high-quality healthcare.

By merging Metran’s advanced development capabilities in respiratory devices with Central Medience’s strengths in supply chain management and medical materials sales, the combined entity aims to enhance the stability of supply systems in the domestic market. Furthermore, they plan to expand their sales channels both domestically and globally to save more lives.

1. Research and Development Synergy


By linking Metran’s advanced respiratory technologies with Central Medience's extensive network in healthcare institutions, product development will be accelerated based on clinical needs. The application of these innovations will not only focus on newborn and pediatric fields but will also explore opportunities in home healthcare.

2. Stabilized Supply System


Central Medience will leverage its supply chain management functions to ensure a consistent supply of Metran products by streamlining the procurement of components, logistics, and maintenance. This approach aims at fortifying product supply, especially during disasters or pandemics.

3. Expansion of Sales Channels


Utilizing Central Medience's nationwide sales network and overseas connections, the company endeavors to broaden the sales reach of Metran products. Their strategic focus on the growing markets in India and Asia will further enhance international brand recognition.

4. Strengthening After-Sales Services


Central Medience plans to enhance maintenance services for Metran products by collaborating with its group companies focusing on medical device maintenance, thus ensuring rapid and high-quality service that improves user satisfaction and builds long-term trust.

5. Operational Efficiency and Cost Reduction


By integrating the inventory management and logistics framework of both companies, they aim to maximize economies of scale. Cost-saving benefits will be reinvested into product development and improved services to build a sustainable growth model.

6. Creating Social Value


By combining Metran’s mission of “Saving Newborn Lives” with Central Medience's principle of “Never Stop Medical Care,” the organizations will provide immense value to society. The objective is to expand Japanese medical technology globally, saving more patients' lives.

With both companies working together as a unified entity, they will achieve a consistent framework spanning development, supply, sales, and after-sales services while enhancing their competitiveness in both domestic and international markets. Central Medience and Metran express their gratitude for the continued support they receive from partners and stakeholders.

Company Overview of Metran


  • - Company Name: Metran Co., Ltd.
  • - Location: 2-12-18 Kawaguchi, Kawaguchi City, Saitama
  • - CEO: Shinichi Nakane
  • - Established: July 14, 1984
  • - Website: www.metran.co.jp

Company Overview of Central Medience


  • - Company Name: Central Medience Co., Ltd.
  • - Location: 2-10-1 Toranomon, Toranomon Twin Building EAST, 8th Floor, Minato-ku, Tokyo
  • - CEO: Ryutaro Nakagawa
  • - Established: May 18, 2018
  • - Website: www.centralmedience.com


画像1

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.